CIK: 0001524362 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $207,548 (43.9% shares, 56.1% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUE OWL CAP CORP III | 2,793,366 | $40,280 | 19.4% | $14.42 | — | COM SHS | 69122G102 |
| — | BANDWIDTH INC | 40,250,000 | $32,168 | 15.5% | $0.62 | — | NOTE 0.500% 4/0 | 05988JAD5 |
| ONTF | ON24 INC | 4,240,256 | $27,392 | 13.2% | $22.91 | -72.0% | COM | 68339B104 |
| — | REVANCE THERAPEUTICS INC | 25,000,000 | $24,030 | 11.6% | $0.96 | — | NOTE 1.750% 2/1 | 761330AB5 |
| — | SUMMIT HOTEL PPTYS | 22,664,000 | $21,966 | 10.6% | $0.96 | — | NOTE 1.500% 2/1 | 866082AA8 |
| — | EQUITY COMWLTH | 9,550,000 | $16,904 | 8.1% | $10.55 | — | COM SH BEN INT | 294628102 |
| — | IRONWOOD PHARMACEUTICALS INC | 14,000,000 | $13,035 | 6.3% | $0.90 | — | NOTE 1.500% 6/1 | 46333XAH1 |
| — | TRAVERE THERAPEUTICS INC | 13,000,000 | $12,830 | 6.2% | $0.99 | — | NOTE 2.500% 9/1 | 761299AB2 |
| — | ACCELERATE DIAGNOSTICS INC | 24,685,998 | $12,343 | 5.9% | $0.64 | — | NOTE 5.000%12/1 | 00430HAC6 |
| ESPR | ESPERION THERAPEUTICS INC NE | 3,000,000 | $6,600 | 3.2% | $2.33 | 0.0% | COM | 29664W105 |